End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.55 CNY | +0.35% | +1.79% | -4.89% |
04-15 | Luyan Pharma Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
2023 | Luyan Pharma Co.,Ltd. Announces Board Appointments | CI |
Sales 2022 | 19.46B 2.69B 3.67B | Sales 2023 | 19.85B 2.74B 3.74B | Capitalization | 3.49B 482M 659M |
---|---|---|---|---|---|
Net income 2022 | 345M 47.61M 65.09M | Net income 2023 | 364M 50.24M 68.68M | EV / Sales 2022 | 0.4 x |
Net Debt 2022 | 4.49B 619M 846M | Net Debt 2023 | 4.25B 587M 802M | EV / Sales 2023 | 0.39 x |
P/E ratio 2022 |
9.36
x | P/E ratio 2023 |
9.56
x | Employees | 5,475 |
Yield 2022 |
3.6% | Yield 2023 |
3.34% | Free-Float | 57.22% |
1 day | +0.35% | ||
1 week | +1.79% | ||
Current month | +4.40% | ||
1 month | +7.41% | ||
3 months | +2.76% | ||
6 months | -5.94% | ||
Current year | -4.89% |
Managers | Title | Age | Since |
---|---|---|---|
Jin Xiang Wu
CEO | Chief Executive Officer | 62 | 08-08-31 |
Cong Jin Yang
DFI | Director of Finance/CFO | 55 | 11-10-19 |
Cui Ping Li
BRD | Director/Board Member | 44 | 11-10-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Zhi Yang Lin
BRD | Director/Board Member | 68 | 17-10-18 |
Jin Xiang Wu
CEO | Chief Executive Officer | 62 | 08-08-31 |
Yan Zhao Tang
BRD | Director/Board Member | 56 | 17-10-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 8.55 | +0.35% | 5,502,699 |
24-04-25 | 8.52 | +0.24% | 4,561,356 |
24-04-24 | 8.5 | +0.24% | 5,227,236 |
24-04-23 | 8.48 | -1.17% | 6,545,224 |
24-04-22 | 8.58 | +2.14% | 9,581,714 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.89% | 458M | |
+17.35% | 71.39B | |
+2.39% | 25.1B | |
+5.38% | 8.59B | |
+6.69% | 8.19B | |
-20.96% | 7.91B | |
+0.49% | 4.54B | |
+17.12% | 4.31B | |
-2.61% | 3.86B | |
+22.08% | 3.64B |
- Stock Market
- Equities
- 002788 Stock